Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

被引：111
|
作者：
Choo, Eun Ju [1 ]
Chambers, Henry F. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Dept Med, Div Infect Dis, Bucheon, South Korea
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA
来源：
INFECTION AND CHEMOTHERAPY | 2016年 / 48卷 / 04期
关键词：
Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment;
D O I：
10.3947/ic.2016.48.4.267
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
引用
收藏
页码：267 / 273
页数：7
相关论文
共 50 条
  • [1] Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Usery, Justin B.
    Vo, Ngan H.
    Finch, Christopher K.
    Cleveland, Kerry O.
    Gelfand, Michael S.
    Self, Timothy H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (01) : 36 - 41
  • [2] Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia
    Cosgrove, Sara E.
    Fowler, Vance G., Jr.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (06) : 624 - 631
  • [3] Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients
    Kan, Li-Ping
    Lin, Jung-Chung
    Chiu, Sheng-Kang
    Yeh, Yen-Cheng
    Lin, Te-Yu
    Yang, Ya-Sung
    Wang, Yung-Chih
    Wang, Ning-Chi
    Yeh, Kuo-Ming
    Chang, Feng-Yee
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2014, 47 (01) : 15 - 22
  • [4] Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan
    Isobe, Masaaki
    Uejima, Etsuko
    Seki, Masafumi
    Yamagishi, Yoshiaki
    Miyawaki, Koji
    Yabuno, Kaori
    Masaoka, Mari
    Hamaguchi, Shigeto
    Yoshioka, Nori
    Tomono, Kazunori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) : 841 - 847
  • [5] Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia
    Alison L. Blackman
    Ellen C. Rubin
    Eleanor K. Broadbent
    Karrine D. Brade
    Current Infectious Disease Reports, 2020, 22
  • [6] Bacteremia due to Methicillin-Resistant Staphylococcus aureus New Therapeutic Approaches
    Holubar, Marisa
    Meng, Lina
    Deresinski, Stan
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2016, 30 (02) : 491 - +
  • [7] Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis
    Ruggero, Michael A.
    Peaper, David R.
    Topal, Jeffrey E.
    INFECTIOUS DISEASES, 2015, 47 (06) : 379 - 384
  • [8] Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia
    Lam, Simon W.
    Bauer, Seth R.
    Neuner, Elizabeth A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (06) : E453 - E456
  • [9] Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia
    Kufel, Wesley D.
    Parsels, Katie A.
    Blaine, Bruce E.
    Steele, Jeffrey M.
    Mahapatra, Rahul
    Paolino, Kristopher M.
    Thomas, Stephen J.
    PHARMACOTHERAPY, 2023, 43 (01): : 15 - 23
  • [10] Persistent methicillin-resistant Staphylococcus aureus bacteremia owing to placental abscess
    Maeda, Naomi
    Hagiya, Hideharu
    Takiuchi, Tsuyoshi
    Kusakabe, Shinsuke
    Maeda, Tetsuo
    Kimura, Keigo
    Iwai, Sayuri
    Kawasaki, Keisuke
    Hori, Yumiko
    Morii, Eiichi
    Kanakura, Yuzuru
    Kimura, Tadashi
    Tomono, Kazunori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (12) : 975 - 979
12345